학술논문
First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States
Document Type
Review Article
Author
Source
In Cancer Treatment Reviews May 2024 126
Subject
Language
ISSN
0305-7372